307 related articles for article (PubMed ID: 25758994)
1. The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome.
Frank M; Albuisson J; Ranque B; Golmard L; Mazzella JM; Bal-Theoleyre L; Fauret AL; Mirault T; Denarié N; Mousseaux E; Boutouyrie P; Fiessinger JN; Emmerich J; Messas E; Jeunemaitre X
Eur J Hum Genet; 2015 Dec; 23(12):1657-64. PubMed ID: 25758994
[TBL] [Abstract][Full Text] [Related]
2. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.
Shalhub S; Byers PH; Hicks KL; Charlton-Ouw K; Zarkowsky D; Coleman DM; Davis FM; Regalado ES; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Behrendt CA; Debus ES; von Kodolitsch Y; Powell RJ; Pepin M; Milewicz DM; Lawrence PF; Woo K
J Vasc Surg; 2019 Nov; 70(5):1543-1554. PubMed ID: 31126764
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.
Chiarelli N; Carini G; Zoppi N; Ritelli M; Colombi M
PLoS One; 2018; 13(1):e0191220. PubMed ID: 29346445
[TBL] [Abstract][Full Text] [Related]
4. Atypical COL3A1 variants (glutamic acid to lysine) cause vascular Ehlers-Danlos syndrome with a consistent phenotype of tissue fragility and skin hyperextensibility.
Ghali N; Baker D; Brady AF; Burrows N; Cervi E; Cilliers D; Frank M; Germain DP; Hulmes DJS; Jacquemont ML; Kannu P; Lefroy H; Legrand A; Pope FM; Robertson L; Vandersteen A; von Klemperer K; Warburton R; Whiteford M; van Dijk FS
Genet Med; 2019 Sep; 21(9):2081-2091. PubMed ID: 30837697
[TBL] [Abstract][Full Text] [Related]
5. A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis.
Shalhub S; Byers PH; Hicks KL; Coleman DM; Davis FM; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Charlton-Ouw K; Behrendt CA; Debus ES; von Kodolitsch Y; Zarkowsky D; Powell RJ; Pepin M; Milewicz DM; Regalado ES; Lawrence PF; Woo K
J Vasc Surg; 2020 Jan; 71(1):149-157. PubMed ID: 31353273
[TBL] [Abstract][Full Text] [Related]
6. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
[TBL] [Abstract][Full Text] [Related]
7. Vascular Ehlers-Danlos Syndrome With a Novel Missense COL3A1 Mutation Present With Pulmonary Complications and Iliac Arterial Dissection.
Gu G; Yang H; Cui L; Fu Y; Li F; Zhou Z; Zheng Y
Vasc Endovascular Surg; 2018 Feb; 52(2):138-142. PubMed ID: 29216800
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing and a novel COL3A1 mutation associated with vascular Ehlers-Danlos syndrome with severe intestinal involvement: a case report.
Cortini F; Marinelli B; Seia M; De Giorgio B; Pesatori AC; Montano N; Bassotti A
J Med Case Rep; 2016 Oct; 10(1):303. PubMed ID: 27799058
[TBL] [Abstract][Full Text] [Related]
9. Clinical, structural, biochemical and X-ray crystallographic correlates of pathogenicity for variants in the C-propeptide region of the COL3A1 gene.
Stembridge NS; Vandersteen AM; Ghali N; Sawle P; Nesbitt M; Pollitt RC; Ferguson DJ; Holden S; Elmslie F; Henderson A; Hulmes DJ; Pope FM
Am J Med Genet A; 2015 Aug; 167A(8):1763-72. PubMed ID: 25846194
[TBL] [Abstract][Full Text] [Related]
10. Two closely spaced missense COL3A1 variants in cis cause vascular Ehlers-Danlos syndrome in one large Chinese family.
Liang M; Chen C; Dai Y; Chang Y; Gao Y
J Cell Mol Med; 2022 Jan; 26(1):144-150. PubMed ID: 34845833
[TBL] [Abstract][Full Text] [Related]
11. A New COL3A1 Mutation in Ehlers-Danlos Syndrome Vascular Type With Different Phenotypes in the Same Family.
Cortini F; Marinelli B; Romi S; Seresini A; Pesatori AC; Seia M; Montano N; Bassotti A
Vasc Endovascular Surg; 2017 Apr; 51(3):141-145. PubMed ID: 28183226
[TBL] [Abstract][Full Text] [Related]
12. Splenic artery pathology presentation, operative interventions, and outcomes in 88 patients with vascular Ehlers-Danlos syndrome.
Shalhub S; Nkansah R; El-Ghazali A; Hillenbrand CJ; Vaidya SS; Schwarze U; Byers PH
J Vasc Surg; 2023 Aug; 78(2):394-404. PubMed ID: 37068529
[TBL] [Abstract][Full Text] [Related]
13. Vascular Ehlers-Danlos Syndrome: A Comprehensive Natural History Study in a Dutch National Cohort of 142 Patients.
Demirdas S; van den Bersselaar LM; Lechner R; Bos J; Alsters SIM; Baars MJH; Baas AF; Baysal Ö; van der Crabben SN; Dulfer E; Giesbertz NAA; Helderman-van den Enden ATJM; Hilhorst-Hofstee Y; Kempers MJE; Komdeur FL; Loeys B; Majoor-Krakauer D; Ockeloen CW; Overwater E; van Tintelen PJ; Voorendt M; de Waard V; Maugeri A; Brüggenwirth HT; van de Laar IMBH; Houweling AC
Circ Genom Precis Med; 2024 Jun; 17(3):e003978. PubMed ID: 38623759
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive genetic screening for vascular Ehlers-Danlos syndrome through an amplification-based next-generation sequencing system.
Yamaguchi T; Hayashi S; Hayashi D; Matsuyama T; Koitabashi N; Ogiwara K; Noda M; Nakada C; Fujiki S; Furutachi A; Tanabe Y; Yamanaka M; Ishikawa A; Mizukami M; Mizuguchi A; Sugiura K; Sumi M; Yamazawa H; Izawa A; Wada Y; Fujikawa T; Takiguchi Y; Wakui K; Takano K; Nishio SY; Kosho T
Am J Med Genet A; 2023 Jan; 191(1):37-51. PubMed ID: 36189931
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in COL3A1 associates to vascular Ehlers-Danlos syndrome with predominant musculoskeletal involvement.
Ruscitti F; Trevisan L; Rosti G; Gotta F; Cianflone A; Geroldi A; Origone P; Pichiecchio A; Viglio S; Iascone M; Mandich P
Mol Genet Genomic Med; 2021 Sep; 9(9):e1753. PubMed ID: 34318601
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic features of 20 Japanese patients with vascular-type Ehlers-Danlos syndrome.
Shimaoka Y; Kosho T; Wataya-Kaneda M; Funakoshi M; Suzuki T; Hayashi S; Mitsuhashi Y; Isei T; Aoki Y; Yamazaki K; Ono M; Makino K; Tanaka T; Kunii E; Hatamochi A
Br J Dermatol; 2010 Oct; 163(4):704-10. PubMed ID: 20518783
[TBL] [Abstract][Full Text] [Related]
17. A Novel Frameshift COL3A1 Variant in Vascular Ehlers-Danlos Syndrome.
Olson SL; Murray ML; Skeik N
Ann Vasc Surg; 2019 Nov; 61():472.e9-472.e13. PubMed ID: 31394236
[TBL] [Abstract][Full Text] [Related]
18. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.
Eder J; Laccone F; Rohrbach M; Giunta C; Aumayr K; Reichel C; Trautinger F
Exp Dermatol; 2013 Mar; 22(3):231-4. PubMed ID: 23489429
[TBL] [Abstract][Full Text] [Related]
19. Nonsyndromic arteriopathy and aortopathy and vascular Ehlers-Danlos syndrome causing COL3A1 variants.
Yagi H; Takeda N; Amiya E; Akiyama N; Chang H; Ishiura H; Sato J; Akazawa H; Morita H; Komuro I
Am J Med Genet A; 2022 Sep; 188(9):2777-2782. PubMed ID: 35543214
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived extracellular matrix demonstrates role of COL3A1 in blood vessel mechanics.
Doherty EL; Aw WY; Warren EC; Hockenberry M; Whitworth CP; Krohn G; Howell S; Diekman BO; Legant WR; Nia HT; Hickey AJ; Polacheck WJ
Acta Biomater; 2023 Aug; 166():346-359. PubMed ID: 37187299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
